Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
The Korean Journal of Parasitology ; : 151-162, 2014.
Artigo em Inglês | WPRIM | ID: wpr-20005

RESUMO

The technique of stem cells or hepatocytes transplantation has recently improved in order to bridge the time before whole-organ liver transplantation. In the present study, unfractionated bone marrow stem cells (BMSCs) were harvested from the tibial and femoral marrow compartments of male mice, which were cultured in Dulbecco's modified Eagle's medium (DMEM) with and without hepatocyte growth factor (HGF), and then transplanted into Schistosoma mansoni-infected female mice on their 8th week post-infection. Mice were sacrificed monthly until the third month of bone marrow transplantation, serum was collected, and albumin concentration, ALT, AST, and alkaline phosphatase (ALP) activities were assayed. On the other hand, immunohistopathological and immunohistochemical changes of granuloma size and number, collagen content, and cells expressing OV-6 were detected for identification of liver fibrosis. BMSCs were shown to differentiate into hepatocyte-like cells. Serum ALT, AST, and ALP were markedly reduced in the group of mice treated with BMSCs than in the untreated control group. Also, granuloma showed a marked decrease in size and number as compared to the BMSCs untreated group. Collagen content showed marked decrease after the third month of treatment with BMSCs. On the other hand, the expression of OV-6 increased detecting the presence of newly formed hepatocytes after BMSCs treatment. BMSCs with or without HGF infusion significantly enhanced hepatic regeneration in S. mansoni-induced fibrotic liver model and have pathologic and immunohistopathologic therapeutic effects. Also, this new therapeutic trend could generate new hepatocytes to improve the overall liver functions.


Assuntos
Animais , Feminino , Masculino , Camundongos , Alanina Transaminase/sangue , Fosfatase Alcalina/sangue , Antígenos de Diferenciação/biossíntese , Aspartato Aminotransferases/sangue , Células da Medula Óssea/citologia , Transplante de Medula Óssea , Diferenciação Celular , Terapia Baseada em Transplante de Células e Tecidos , Células Cultivadas , Colágeno/metabolismo , Granuloma/parasitologia , Fator de Crescimento de Hepatócito/farmacologia , Hepatócitos/citologia , Fígado/parasitologia , Cirrose Hepática/parasitologia , Camundongos Endogâmicos BALB C , Schistosoma mansoni/patogenicidade , Esquistossomose mansoni/mortalidade , Transplante de Células-Tronco , Células-Tronco/citologia
2.
Artigo em Inglês | IMSEAR | ID: sea-89549

RESUMO

Results of the long-term effects of two schedules of radioiodine therapy I131 in 130 toxic multinodular goitre patients were evaluated. Seventy five patients (group I) were treated with low doses and 55 patients (group II) with calculated high doses adjusted for thyroid weight (0.5-1 mci/g) and radioiodine uptake. Follow up (mean +/- SEM) was 4.5 +/- 0.4 years and 4.8 +/- 0.6 years respectively (P > 0.1). At the end of follow up, hyperthyroidism was successfully reversed in 78% (Group I) and 82% (Group II). In group I hypothyroidism was present in 5% of patients, while it was 12.5% in group II patients. The total dose per gram of thyroid tissue was not significantly different in both the groups (.058 mci +/- .0054 VS .073 +/- .0054 mci/g). However in group II the number of I131 administration was significantly lower (1.5 +/- 0.2) than in group I (3.2 +/- 0.4). The percentage of patients who were adequately treated in Group II with single dose was more as compared in group I (62% in group II versus 40% in group I). Euthyroidism was reached in a shorter time after treatment in group II (median time 0.8 year in group II Vs 1.1 yrs in group I) It is concluded that radioiodine is an effective treatment for toxic multinodular goitre with a significant low incidence of post therapy hypothyroidism in patients treated with low doses as compared to higher doses of radioiodine therapy.


Assuntos
Adulto , Feminino , Seguimentos , Bócio Nodular/complicações , Humanos , Hipertireoidismo/etiologia , Hipotireoidismo/etiologia , Radioisótopos do Iodo/administração & dosagem , Masculino , Pessoa de Meia-Idade , Dosagem Radioterapêutica , Indução de Remissão , Estudos Retrospectivos , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA